Considerations for Anticoagulation and Endocarditis Risk in Invasive Dental Procedures: Expert Approaches and Preventive Strategies
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Cardiovascular diseases are globally prevalent conditions with high mortality and morbidity rates. As the elderly population increases, the proportion of individuals affected by these diseases is on the rise. In line, dentists frequently encounter patients taking anticoagulants for cardiovascular conditions and those at a higher risk of infective endocarditis due to heart valverelated issues. Dentists need to be mindful of considerations during invasive dental procedures. For individuals at a high risk of infective endocarditis, preventive antibiotic therapy, regular dental check-ups and oral hygiene management are essential. Although, temporary discontinuation of anticoagulant therapy has been done to reduce bleeding risk, it is recommended not to stop anticoagulation due to the increased risk of thromboembolic events, which can lead to death. Instead, employing local methods such as appropriate hemostatic agents is advisable.
Abstract
Cardiovascular diseases are globally prevalent conditions with high mortality and morbidity rates. As the elderly population increases, the proportion of individuals affected by these diseases is on the rise. In line, dentists frequently encounter patients taking anticoagulants for cardiovascular conditions and those at a higher risk of infective endocarditis due to heart valverelated issues. Dentists need to be mindful of considerations during invasive dental procedures. For individuals at a high risk of infective endocarditis, preventive antibiotic therapy, regular dental check-ups and oral hygiene management are essential. Although, temporary discontinuation of anticoagulant therapy has been done to reduce bleeding risk, it is recommended not to stop anticoagulation due to the increased risk of thromboembolic events, which can lead to death. Instead, employing local methods such as appropriate hemostatic agents is advisable.
참고문헌 (45)
- Deaton C, "The global burden of cardiovascular disease", Eur J Cardiovasc Nur, 10, pp.S5~S13 (2011)
- Hyeok-Hee Lee, "Korea Heart Disease Fact Sheet 2020: Analysis of Nationwide Data", Korean Circulation Journal, 51(6), pp.495~503 (2021), 대한심장학회[DOI]
- Silvestre FJ, "Dental management of the patient with ischemic heart disease : an update", Med Oral, 7, pp.222~230 (2002)
- Hong C, "Risk of postoperative bleeding after dental procedures in patients on warfarin : a retrospective study", Oral Surg Oral Med Oral Pathol Oral Radiol, 114, pp.464~468 (2012)
- Thornhill MH, "Antibiotic Prophylaxis Against Infective Endocarditis Before Invasive Dental Procedures", J Am Coll Cardiol, 80, pp.1029~1041 (2022)
- Koskinas KC, "Dental management of antiplatelet-receiving patients : is uninterrupted antiplatelet therapy safe?", Angiology, 63, pp.245~247 (2012)
- Seymour RA, "Cardiovascular diseases and periodontology", J Clin Periodontol, 30, pp.279~292 (2003)
- Wilson WR, "Prevention of Viridans Group Streptococcal Infective Endocarditis : A Scientific Statement From the American Heart Association", Circulation, 143, pp.e963~e978 (2021)
- Tubiana S, "Dental procedures, antibiotic prophylaxis, and endocarditis among people with prosthetic heart valves: nationwide population based cohort and a case crossover study", Bmj-Brit Med J, pp.358~ (2017)
- Lockhart PB, "Bacteremia associated with toothbrushing and dental extraction", Circulation, 117, pp.3118~3125 (2008)
- Jensen AD, "Temporal trends of mortality in patients with infective endocarditis : a nationwide study", Eur Heart J Qual Care Clin Outcomes, 9, pp.24~33 (2022)
- Cahill TJ, "Infective endocarditis", Lancet, 387, pp.882~893 (2016)
- Ahrens I, "New oral anticoagulant drugs in cardiovascular disease", Thromb Haemostasis, 104, pp.49~60 (2010)
- Fleg JL, "Cardiovascular drug therapy in the elderly : benefits and challenges", Nat Rev Cardiol, 8, pp.13~28 (2011)
- Kammerer PW, "Oral surgery during therapy with anticoagulants-a systematic review", Clin Oral Investig, 19, pp.171~180 (2015)
- Al-Mubarak S, "Thromboembolic risk and bleeding in patients maintaining or stopping oral anticoagulant therapy during dental extraction", J Thromb Haemost, 4, pp.689~691 (2006)
- Mehra P, "Management of heparin therapy in the high-risk, chronically anticoagulated, oral surgery patient : a review and a proposed nomogram", J Oral Maxillofac Surg, 58, pp.198~202 (2000)
- Aldridge E, "Current thoughts on treatment of patients receiving anticoagulation therapy", J Oral Maxillofac Surg, 68, pp.2879~2887 (2010)
- Wahl MJ, "Dental surgery in anticoagulated patients--stop the interruption", Oral Surg Oral Med Oral Pathol Oral Radiol, 119, pp.136~157 (2015)
- Whitlock RP, "Antithrombotic and thrombolytic therapy for valvular disease : Antithrombotic Therapy and Prevention of Thrombosis, 9th ed : American College of Chest Physicians Evidence-Based Clinical Practice Guidelines", Chest, 141, pp.e576~e600 (2012)
- Aframian DJ, "Management of dental patients taking common hemostasis-altering medications", Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 103(Suppl:S45), pp.e41~ (2007)
- Russo G, "Simple and safe method to prepare patients with prosthetic heart valves for surgical dental procedures", Clin Appl Thromb Hemost, 6, pp.90~93 (2000)
- Nikolakopoulos I, "Heparin Bridging Therapy for Patients on Chronic Oral Anticoagulants in Periprocedural Settings", Semin Thromb Hemost, 46, pp.26~31 (2020)
- Mathew JG, "Efficacy and safety of early parenteral anticoagulation as a bridge to warfarin after mechanical valve replacement", Thromb Haemost, 112, pp.1120~1128 (2014)
- Douketis JD, "Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation", N Engl J Med, 373, pp.823~833 (2015)
- Douketis JD, "Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure. Substudy of the RE-LY trial", Thromb Haemost, 113, pp.625~632 (2015)
- Nematullah A, "Dental surgery for patients on anticoagulant therapy with warfarin : a systematic review and meta-analysis", J Can Dent Assoc, 75, pp.41~ (2009)
- Douketis JD, "Perioperative Management of Antithrombotic Therapy : An American College of Chest Physicians Clinical Practice Guideline", Chest, 162, pp.1127~1139 (2022)
- Renvert S, "Treatment of periodontal disease in older adults", Periodontology 2000, 72, pp.108~119 (2016)
- Nathwani S, "Novel oral anticoagulants and exodontia : the evidence", Br Dent J, 222, pp.623~628 (2017)
- Bensi C, "Postoperative bleeding risk of direct oral anticoagulants after oral surgery procedures : a systematic review and meta-analysis", Int J Oral Maxillofac Surg, 47, pp.923~932 (2018)
- Gomez-Moreno G, "Dental implant surgery in patients in treatment by dabigatran", Clin Oral Implants Res, 29, pp.644~648 (2018)
- Hanken H, "Postoperative bleeding risk for oral surgery under continued rivaroxaban anticoagulant therapy", Clin Oral Investig, 20, pp.1279~1282 (2016)
- Clemm R, "Management of anticoagulated patients in implant therapy : a clinical comparative study", Clin Oral Implants Res, 27, pp.1274~1282 (2016)
- Cappare P, "Postoperative Bleeding in Patients Under Direct Oral Anticoagulation After Maxillary Sinus Floor Augmentation : A Case-Control Study", Int J Oral Maxillofac Implants, 37, pp.365~372 (2022)
- Miclotte I, "Pragmatic approach to manage new oral anticoagulants in patients undergoing dental extractions : a prospective case-control study", Clin Oral Investig, 21, pp.2183~2188 (2017)
- Nagao T, "Impact of periprocedural anticoagulation therapy on the incidence of silent stroke after atrial fibrillation ablation in patients receiving direct oral anticoagulants : uninterrupted vs. interrupted by one dose strategy", Europace, 21, pp.590~597 (2019)
- Nakamura K, "Uninterrupted vs. interrupted periprocedural direct oral anticoagulants for catheter ablation of atrial fibrillation : a prospective randomized single-centre study on post-ablation thrombo-embolic and haemorrhagic events", Europace, 21, pp.259~267 (2019)
- Shah S, "Perioperative Management of Vitamin K Antagonists and Direct Oral Anticoagulants : A Systematic Review and Meta-analysis", Chest, 163, pp.1245~1257 (2023)
- Sherwood MW, "Outcomes of temporary interruption of rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation : results from the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation(ROCKET AF)", Circulation, 129, pp.1850~1859 (2014)
- Cocero N, "Direct Oral Anticoagulants and Medical Comorbidities in Patients Needing Dental Extractions : Management of the Risk of Bleeding", J Oral Maxillofac Surg, 77, pp.463~470 (2019)
- Buchbender M, "Management of anticoagulated patients in dentoalveolar surgery : a retrospective study comparing bridging with heparin versus unpaused vitamin K antagonist medication", BMC Oral Health, 21, pp.96~ (2021)
- Mahardawi B, "The effect of different hemostatic agents following dental extraction in patients under oral antithrombotic therapy : a network meta-analysis", Sci Rep, 13, pp.12519~ (2023)
- Ranganathan M, "Assessment of Regeneration of Bone in the Extracted Third Molar Sockets Augmented Using Xenograft(CollaPlug(TN)Zimmer)in Comparison with the Normal Healing on the Contralateral Side", J Pharm Bioallied Sci, 9, pp.S180~S186 (2017)
- Cziperle DJ, "Avitene Microfibrillar Collagen Hemostat for Adjunctive Hemostasis in Surgical Procedures : A Systematic Literature Review", Med Devices(Auckl), 14, pp.155~163 (2021)
